Deep Learning for Targeted Treatments: Transformation in Healthcare

Beschreibung:

In. Bestandsnummer des Verkäufers ria9781119857327_new

Diesen Artikel melden

Inhaltsangabe:

Über die Autorin bzw. den Autor:

Rishabha Malviya, PhD, is an associate professor in the Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University. His areas of interest include formulation optimization, nanoformulation, targeted drug delivery, localized drug delivery, and characterization of natural polymers as pharmaceutical excipients. He has authored more than 150 research/review papers for national/international journals of repute. He has been granted more than 10 patents from different countries while a further 40 patents are published/under evaluation.

Gheorghita Ghinea, PhD, is a professor in Computing, Department of Computer Science Brunel University London. His research activities lie at the confluence of computer science, media, and psychology, and particularly interested in building semantically underpinned human-centered e-systems, particularly integrating human perceptual requirements. Has published more than 30+ articles and received 10+ research grants.

Rajesh Kumar Dhanaraj, PhD, is an associate professor in the School of Computing Science and Engineering at Galgotias University, Greater Noida, India. He has contributed 20+ books on various technologies and 35+ articles and papers in various refereed journals and international conferences and contributed chapters to the books. His research interests include machine learning, cyber-physical systems, and wireless sensor networks. He is an Expert Advisory Panel Member of Texas Instruments Inc USA.

Balamurugan Balusamy, PhD, is a professor at Galgotias University. He has published 30+ books on various technologies as well as more than 150 journal articles, conferences, and book chapters.

Sonali Sundram completed B. Pharm & M. Pharm (pharmacology) from AKTU, Lucknow, and is working at Galgotias University, Greater Noida. Her areas of interest are neurodegeneration, clinical research, and artificial intelligence. She has more than 8 patents to her credit.